An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
about
siRNA Delivery by Stimuli-Sensitive NanocarriersGadolinium embedded iron oxide nanoclusters as T1-T2 dual-modal MRI-visible vectors for safe and efficient siRNA deliveryEngineering anti-GD2 monoclonal antibodies for cancer immunotherapy.An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude miceAn MRI-visible non-viral vector bearing GD2 single chain antibody for targeted gene delivery to human bone marrow mesenchymal stem cells.Antibody fragments as nanoparticle targeting ligands: a step in the right directionLow-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.Applications and potential toxicity of magnetic iron oxide nanoparticles.Polyethylenimines for siRNA and miRNA delivery in vivo.Multimodality imaging of RNA interferenceSurface modification of nonviral nanocarriers for enhanced gene delivery.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.Imaging-guided delivery of RNAi for anticancer treatment.Gene therapy as a potential tool for treating neuroblastoma-a focused review.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma.
P2860
Q26781212-9F639254-4DAE-4EBF-BD59-AE499FFC9109Q30657167-931DA150-5FC2-41F1-AC2E-BBDA6F30E810Q34389202-B6016070-6E27-4BF4-B589-0F4F6164DEA1Q34901473-EFBE7F07-C6C0-4805-A131-F4A36AF5BBAEQ35014757-2C734325-0011-4CB4-AE64-3D361A2628A8Q36357291-97ECFC42-ED5B-4EA3-B218-0BA5051D3D68Q36919338-BBB62666-5E26-4EC5-86A8-2D3C8350804EQ38047272-0359D390-B61B-48E5-9EE8-F163AA52F5FAQ38110474-F67C3028-3776-451F-8915-7B7851017285Q38112726-A6A7E6B7-CB18-484D-96A1-A3600967FEAFQ38172635-43488486-1529-4C67-B341-F25E0A03D85DQ38217461-7A6C27CA-5692-473A-AF6F-DD6C4124E8C3Q38388106-731C892B-CB6A-46AD-A2E0-3C1D81C80910Q38710046-903BBE43-EDFA-4E64-B7F7-45BC82B57769Q38808728-80C11046-27E0-4BD4-9D27-AE4BDDE7C669Q47152520-8E110E9C-CAFB-4AB7-9315-17098AB1DEB0Q50123721-E206D9F1-726F-4B51-9DC1-EAC25D47AB37Q52568577-34BEEAFA-A9B7-4815-821B-E456F34DED6C
P2860
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@ast
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@en
type
label
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@ast
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@en
prefLabel
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@ast
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@en
P2093
P2860
P356
P1476
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
@en
P2093
Faming Gong
Kangshun Zhu
Pengfei Pang
Xiaochun Meng
P2860
P304
P356
10.2147/IJN.S32900
P407
P50
P577
2012-07-02T00:00:00Z